250 related articles for article (PubMed ID: 22782690)
1. Mapping of the PDQ-39 to EQ-5D scores in patients with Parkinson's disease.
Young MK; Ng SK; Mellick G; Scuffham PA
Qual Life Res; 2013 Jun; 22(5):1065-72. PubMed ID: 22782690
[TBL] [Abstract][Full Text] [Related]
2. Converting Parkinson-Specific Scores into Health State Utilities to Assess Cost-Utility Analysis.
Chen G; Garcia-Gordillo MA; Collado-Mateo D; Del Pozo-Cruz B; Adsuar JC; Cordero-Ferrera JM; Abellán-Perpiñán JM; Sánchez-Martínez FI
Patient; 2018 Dec; 11(6):665-675. PubMed ID: 29876865
[TBL] [Abstract][Full Text] [Related]
3. Validation and comparison of 15-D and EQ-5D-5L instruments in a Spanish Parkinson's disease population sample.
García-Gordillo M; del Pozo-Cruz B; Adsuar JC; Sánchez-Martínez FI; Abellán-Perpiñán JM
Qual Life Res; 2014 May; 23(4):1315-26. PubMed ID: 24258254
[TBL] [Abstract][Full Text] [Related]
4. The EQ-5D--a generic quality of life measure-is a useful instrument to measure quality of life in patients with Parkinson's disease.
Schrag A; Selai C; Jahanshahi M; Quinn NP
J Neurol Neurosurg Psychiatry; 2000 Jul; 69(1):67-73. PubMed ID: 10864606
[TBL] [Abstract][Full Text] [Related]
5. Convergent validation of EQ-5D-5L in patients with Parkinson's disease.
Alvarado-Bolaños A; Cervantes-Arriaga A; Rodríguez-Violante M; Llorens-Arenas R; Calderón-Fajardo H; Millán-Cepeda R; Leal-Ortega R; Estrada-Bellmann I; Zuñiga-Ramírez C
J Neurol Sci; 2015 Nov; 358(1-2):53-7. PubMed ID: 26276513
[TBL] [Abstract][Full Text] [Related]
6. Assessment of the construct validity and responsiveness of preference-based quality of life measures in people with Parkinson's: a systematic review.
Xin Y; McIntosh E
Qual Life Res; 2017 Jan; 26(1):1-23. PubMed ID: 27778141
[TBL] [Abstract][Full Text] [Related]
7. Mapping from the Parkinson's Disease Questionnaire PDQ-39 to the Generic EuroQol EQ-5D-3L: The Value of Mixture Models.
Kent S; Gray A; Schlackow I; Jenkinson C; McIntosh E
Med Decis Making; 2015 Oct; 35(7):902-11. PubMed ID: 25926283
[TBL] [Abstract][Full Text] [Related]
8. Mapping the eight-item Parkinson's Disease Questionnaire (PDQ-8) to the EQ-5D utility index.
Cheung YB; Tan LC; Lau PN; Au WL; Luo N
Qual Life Res; 2008 Nov; 17(9):1173-81. PubMed ID: 18807209
[TBL] [Abstract][Full Text] [Related]
9. Relationship between the MDS-UPDRS domains and the health-related quality of life of Parkinson's disease patients.
Martínez-Martín P; Rodríguez-Blázquez C; Forjaz MJ; Alvarez-Sánchez M; Arakaki T; Bergareche-Yarza A; Chade A; Garretto N; Gershanik O; Kurtis MM; Martínez-Castrillo JC; Mendoza-Rodríguez A; Moore HP; Rodríguez-Violante M; Singer C; Tilley BC; Huang J; Stebbins GT; Goetz CG
Eur J Neurol; 2014 Mar; 21(3):519-24. PubMed ID: 24447695
[TBL] [Abstract][Full Text] [Related]
10. A study of the relationship between health and subjective well-being in Parkinson's disease patients.
Cubí-Mollá P; de Vries J; Devlin N
Value Health; 2014 Jun; 17(4):372-9. PubMed ID: 24968997
[TBL] [Abstract][Full Text] [Related]
11. Is EQ-5D a valid quality of life instrument in patients with Parkinson's disease? A study in Singapore.
Luo N; Low S; Lau PN; Au WL; Tan LC
Ann Acad Med Singap; 2009 Jun; 38(6):521-8. PubMed ID: 19565103
[TBL] [Abstract][Full Text] [Related]
12. Does quality of life of COPD patients as measured by the generic EuroQol five-dimension questionnaire differentiate between COPD severity stages?
Rutten-van Mölken MP; Oostenbrink JB; Tashkin DP; Burkhart D; Monz BU
Chest; 2006 Oct; 130(4):1117-28. PubMed ID: 17035446
[TBL] [Abstract][Full Text] [Related]
13. The Validity of Health-Related Quality of Life Instruments in Patients With Late-Stage Parkinson's Disease.
Ramadhan M; Schrag A;
J Geriatr Psychiatry Neurol; 2023 May; 36(3):225-232. PubMed ID: 36264078
[TBL] [Abstract][Full Text] [Related]
14. A comparison of the scaling properties of the English, Spanish, French, and Chinese EQ-5D descriptive systems.
Luo N; Li M; Chevalier J; Lloyd A; Herdman M
Qual Life Res; 2013 Oct; 22(8):2237-43. PubMed ID: 23266797
[TBL] [Abstract][Full Text] [Related]
15. Responsiveness of the EQ-5D and 8-item Parkinson's Disease Questionnaire (PDQ-8) in a 4-year follow-up study.
Luo N; Ng WY; Lau PN; Au WL; Tan LC
Qual Life Res; 2010 May; 19(4):565-9. PubMed ID: 20204708
[TBL] [Abstract][Full Text] [Related]
16. Mapping the EQ-5D index by UPDRS and PDQ-8 in patients with Parkinson's disease.
Dams J; Klotsche J; Bornschein B; Reese JP; Balzer-Geldsetzer M; Winter Y; Schrag A; Siderowf A; Oertel WH; Deuschl G; Siebert U; Dodel R
Health Qual Life Outcomes; 2013 Mar; 11():35. PubMed ID: 23497005
[TBL] [Abstract][Full Text] [Related]
17. Do English and Chinese EQ-5D versions demonstrate measurement equivalence? An exploratory study.
Luo N; Chew LH; Fong KY; Koh DR; Ng SC; Yoon KH; Vasoo S; Li SC; Thumboo J
Health Qual Life Outcomes; 2003 Apr; 1():7. PubMed ID: 12756060
[TBL] [Abstract][Full Text] [Related]
18. Mapping the SRS-22r questionnaire onto the EQ-5D-5L utility score in patients with adolescent idiopathic scoliosis.
Wong CKH; Cheung PWH; Samartzis D; Luk KD; Cheung KMC; Lam CLK; Cheung JPY
PLoS One; 2017; 12(4):e0175847. PubMed ID: 28414745
[TBL] [Abstract][Full Text] [Related]
19. Changes in health-related quality of life of Chinese populations measured by the EQ-5D-3 L: a comparison of the 2008 and 2013 National Health Services Surveys.
Yao Q; Liu C; Zhang Y; Xu L
Health Qual Life Outcomes; 2019 Mar; 17(1):43. PubMed ID: 30866953
[TBL] [Abstract][Full Text] [Related]
20. Real-world assessment of the impact of "OFF" episodes on health-related quality of life among patients with Parkinson's disease in the United States.
Thach A; Jones E; Pappert E; Pike J; Wright J; Gillespie A
BMC Neurol; 2021 Jan; 21(1):46. PubMed ID: 33516182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
